Cargando…

Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia

Detalles Bibliográficos
Autores principales:	Nassar, YS, Ibrahim, M, Salman, AG, Elgohary, TS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797969/ http://dx.doi.org/10.1186/2197-425X-3-S1-A380

Ejemplares similares

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
por: Rakhshan, Amin, et al.
Publicado: (2023)

Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
por: Demirdal, Tuna, et al.
Publicado: (2016)

Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects
por: Torres, Antoni, et al.
Publicado: (2018)

Laryngitis after inhalation of liposomal amikacin
por: Morita, Atsuho, et al.
Publicado: (2022)

Adjunctive inhaled amikacin in infants with ventilator-associated pneumonia optimizes the complex antimicrobial therapy: pilot study
por: Levchenko, Bohdan, et al.
Publicado: (2023)

Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
por: Tavernier, Elsa, et al.
Publicado: (2021)

Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
por: Choe, Junsu, et al.
Publicado: (2019)

NKTR-061 (inhaled amikacin) delivers high lung doses in mechanically ventilated patients with pneumonia and in healthy subjects
por: Eldon, M, et al.
Publicado: (2008)

Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator‐associated pneumonia: An open‐label randomized controlled trial
por: Hakamifard, Atousa, et al.
Publicado: (2023)

Liposomal Amikacin Inhalation Suspension-induced Pneumonitis
por: Kidogawa, Moe, et al.
Publicado: (2022)

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
por: Ammar, Mona Ahmed, et al.
Publicado: (2018)

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
por: Choi, Hee Kyoung, et al.
Publicado: (2014)

Effect of Inhaled Colistin on the Treatment of Ventilator-Associated Pneumonia due to Multi-drug Resistant Acinetobacter
por: Moradi Moghaddam, Omid, et al.
Publicado: (2019)

Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment
por: Wang, Fangzhou, et al.
Publicado: (2021)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
por: Motos, Ana, et al.
Publicado: (2023)

Decrease in intravenous antibiotic use with adjunctive aerosolized amikacin treatment in intubated mechanically ventilated patients with Gram-negative pneumonia
por: Niederman, M, et al.
Publicado: (2007)

Performance of amikacin inhale: impact of supplemental oxygen and device orientation
por: Kadrichu, N, et al.
Publicado: (2015)

Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia
por: Almangour, Thamer A., et al.
Publicado: (2020)

Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection
por: Zheng, Zihao, et al.
Publicado: (2023)

Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
por: Zhang, Jimin, et al.
Publicado: (2018)

A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
por: El Fawy, Dalia M., et al.
Publicado: (2020)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin
por: Chen, Kuan-Jen, et al.
Publicado: (2021)

Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome
por: Jindal, Animesh, et al.
Publicado: (2013)

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia
por: Biagi, Mark, et al.
Publicado: (2019)

In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-β-lactamase-producing Pseudomonas aeruginosa
por: Oie, Shigeharu, et al.
Publicado: (2009)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

In vitro efficiency of Amikacin Inhale, a novel drug-device delivery system
por: Kadrichu, N, et al.
Publicado: (2013)

Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
por: Caimmi, Davide, et al.
Publicado: (2018)

Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
por: Qin, Jun-Ping, et al.
Publicado: (2021)

Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
por: Frantzeskaki, F, et al.
Publicado: (2006)

In Vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia
por: Bayatinejad, Ghazal, et al.
Publicado: (2023)

Inhalation-Pneumonia
por: Williams, W. L., et al.
Publicado: (1897)

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)

Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial
por: Liu, Chang, et al.
Publicado: (2017)

Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
por: Allam, Anas, et al.
Publicado: (2017)

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
por: Yu, Lan, et al.
Publicado: (2019)

Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats
por: Malinin, Vladimir, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hjdrcff3mnfgoeurc6gijbctuj